Patents by Inventor James N. Watson
James N. Watson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11975175Abstract: Methods and systems are provided for determining fluid administration. The system may determine fluid administration based on the fluid responsiveness and regional oxygen saturation of a subject. The system may receive the fluid responsiveness and regional oxygen saturation from external sources or may determine one or both based on received physiological signals. In some embodiments, the system may determine whether to administer fluid based on the fluid responsiveness and regional oxygen saturation. In some embodiments, the system may determine the amount of fluid to administer based on the fluid responsiveness and regional oxygen saturation. In some embodiments, the system may determine the effectiveness of fluid administration. In some embodiments, the system may provide an indication of the determined fluid administration so that a care-giver can implement the appropriate fluid administration. In some embodiments, the system may control the fluid administration based on its determination.Type: GrantFiled: May 21, 2019Date of Patent: May 7, 2024Assignee: COVIDIEN LPInventors: Peter Doyle, Paul S. Addison, James N. Watson
-
Patent number: 11872030Abstract: Methods, systems, and devices for measuring respiratory parameters from an ECG device are described. The method may include receiving an electrocardiogram (ECG) signal associated with a patient. The method may further include detecting a change in modulation of the ECG signal between a first portion of the ECG signal and a second portion of the ECG signal. The method may further include determining a change in respiratory effort of the patient based at least in part on the change in modulation.Type: GrantFiled: July 22, 2020Date of Patent: January 16, 2024Assignee: COVIDIEN LPInventors: Paul Stanley Addison, Daniel Wayne Bartlett, James N. Watson
-
Patent number: 11844624Abstract: A patient monitor for monitoring cerebral activity of a patient may include a processor configured to determine a depth of consciousness index for the patient based on electroencephalography (EEG) data and determine regional oxygen saturation for the patient based on regional oximetry data. Additionally, the processor may be configured to determine a metric associated with cerebral activity of the patient based at least in part on the one or more values of the depth of consciousness index and the one or more regional oxygen saturation values and to provide the one or more values of a depth of consciousness index and the metric to an output device.Type: GrantFiled: September 23, 2020Date of Patent: December 19, 2023Assignee: COVIDIEN LPInventors: James N. Watson, Paul S. Addison
-
SYSTEM AND METHOD FOR PROVIDING BLOOD PRESSURE SAFE ZONE INDICATION DURING AUTOREGULATION MONITORING
Publication number: 20230284914Abstract: A method for monitoring autoregulation includes, using a processor, using a processor to execute one or more routines on a memory. The one or more routines include receiving one or more physiological signals from a patient, determining a correlation-based measure indicative of the patient's autoregulation based on the one or more physiological signals, and generating an autoregulation profile of the patient based on autoregulation index values of the correlation-based measure. The autoregulation profile includes the autoregulation index values sorted into bins corresponding to different blood pressure ranges. The one or more routines also include designating a blood pressure range encompassing one or more of the bins as a blood pressure safe zone indicative of intact regulation and providing a signal to a display to display the autoregulation profile and a first indicator of the blood pressure safe zone.Type: ApplicationFiled: May 19, 2023Publication date: September 14, 2023Inventors: Paul Stanley Addison, James N. Watson, Dean Montgomery -
System and method for providing blood pressure safe zone indication during autoregulation monitoring
Patent number: 11653840Abstract: A method for monitoring autoregulation includes, using a processor, using a processor to execute one or more routines on a memory. The one or more routines include receiving one or more physiological signals from a patient, determining a correlation-based measure indicative of the patient's autoregulation based on the one or more physiological signals, and generating an autoregulation profile of the patient based on autoregulation index values of the correlation-based measure. The autoregulation profile includes the autoregulation index values sorted into bins corresponding to different blood pressure ranges. The one or more routines also include designating a blood pressure range encompassing one or more of the bins as a blood pressure safe zone indicative of intact regulation and providing a signal to a display to display the autoregulation profile and a first indicator of the blood pressure safe zone.Type: GrantFiled: November 6, 2019Date of Patent: May 23, 2023Assignee: COVIDIEN LPInventors: Paul Stanley Addison, James N. Watson, Dean Montgomery -
Patent number: 11317821Abstract: The present invention relates to physiological signal processing, and in particular to methods and systems for processing physiological signals to predict a fluid responsiveness of a patient. A medical monitor for monitoring a patient includes an input receiving a photoplethysmograph (PPG) signal representing light absorption by a patient's tissue. The monitor also includes a perfusion status indicator indicating a perfusion status of the PPG signal, and a fluid responsiveness predictor (FRP) calculator programmed to calculate an FRP value based on a respiratory variation of the PPG signal. The FRP calculator applies a correction factor based on the perfusion status indicator.Type: GrantFiled: September 12, 2017Date of Patent: May 3, 2022Assignee: COVIDIEN LPInventors: Paul Stanley Addison, Rui Wang, Scott McGonigle, James N. Watson
-
Patent number: 11096588Abstract: A method for monitoring autoregulation includes, using a processor, receiving a blood pressure signal an oxygen saturation signal, and a regional oxygen saturation signal from a patient. The method also includes normalizing the regional oxygen saturation signal to correct for variation in the oxygen saturation signal based on a relationship between the oxygen saturation signal and the regional oxygen saturation signal. The method further includes determining a linear correlation between the blood pressure signal and the normalized regional oxygen saturation signal. The method still further includes providing a signal indicative of the patient's autoregulation status to an output device based on the linear correlation.Type: GrantFiled: October 5, 2016Date of Patent: August 24, 2021Assignee: Covidien LPInventors: Paul Stanley Addison, James N. Watson, Dean Montgomery
-
Patent number: 11026586Abstract: In some examples, a device includes processing circuitry configured to receive first and second signals indicative of first and second physiological parameters, respectively, of a patient. The processing circuitry is also configured to determine a first estimate of a limit of autoregulation of the patient based on the first and second signals. The processing circuitry is further configured to determine a difference between the first estimate of the limit of autoregulation and one or more other estimates of the limit of autoregulation. The processing circuitry is configured to determine a weighted average of the first estimate and a previous value of the limit of autoregulation based on the difference between the first estimate and the one or more other estimates. The processing circuitry is configured to determine an autoregulation status based on the weighted average and output, for display via the display, an indication of the autoregulation status.Type: GrantFiled: April 25, 2018Date of Patent: June 8, 2021Assignee: Covidien LPInventors: Paul S. Addison, Dean Montgomery, James N. Watson
-
Publication number: 20210145366Abstract: A method for monitoring autoregulation includes, using a processor, receiving a blood pressure signal, a regional oxygen saturation signal, and a blood volume signal from a patient. The method also includes determining a first linear correlation between the blood pressure signal and the regional oxygen saturation signal and determining a second linear correlation between the blood pressure signal and the blood volume signal. The method also includes determining a confidence level associated with the first linear correlation based at least in part on the second linear correlation and providing a signal indicative of the patient's autoregulation status to an output device based on the linear correlation and the confidence level.Type: ApplicationFiled: January 26, 2021Publication date: May 20, 2021Inventors: Paul S. Addison, Dean Montgomery, James N. Watson
-
Patent number: 10932724Abstract: A method for monitoring autoregulation includes, using a processor, receiving a blood pressure signal, a regional oxygen saturation signal, and a blood volume signal from a patient. The method also includes determining a first linear correlation between the blood pressure signal and the regional oxygen saturation signal and determining a second linear correlation between the blood pressure signal and the blood volume signal. The method also includes determining a confidence level associated with the first linear correlation based at least in part on the second linear correlation and providing a signal indicative of the patient's autoregulation status to an output device based on the linear correlation and the confidence level.Type: GrantFiled: June 16, 2016Date of Patent: March 2, 2021Assignee: Covidien LPInventors: Paul S. Addison, Dean Montgomery, James N. Watson
-
Publication number: 20210000413Abstract: A patient monitor for monitoring cerebral activity of a patient may include a processor configured to determine a depth of consciousness index for the patient based on electroencephalography (EEG) data and determine regional oxygen saturation for the patient based on regional oximetry data. Additionally, the processor may be configured to determine a metric associated with cerebral activity of the patient based at least in part on the one or more values of the depth of consciousness index and the one or more regional oxygen saturation values and to provide the one or more values of a depth of consciousness index and the metric to an output device.Type: ApplicationFiled: September 23, 2020Publication date: January 7, 2021Inventors: James N. Watson, Paul S. Addison
-
Patent number: 10835174Abstract: A patient monitor for monitoring cerebral activity of a patient may include a processor configured to determine a depth of consciousness index for the patient based on electroencephalography (EEG) data and determine regional oxygen saturation for the patient based on regional oximetry data. Additionally, the processor may be configured to determine a metric associated with cerebral activity of the patient based at least in part on the one or more values of the depth of consciousness index and the one or more regional oxygen saturation values and to provide the one or more values of a depth of consciousness index and the metric to an output device.Type: GrantFiled: January 12, 2016Date of Patent: November 17, 2020Assignee: COVIDIEN LPInventors: James N. Watson, Paul S. Addison
-
Publication number: 20200345270Abstract: Methods, systems, and devices for measuring respiratory parameters from an ECG device are described. The method may include receiving an electrocardiogram (ECG) signal associated with a patient. The method may further include detecting a change in modulation of the ECG signal between a first portion of the ECG signal and a second portion of the ECG signal. The method may further include determining a change in respiratory effort of the patient based at least in part on the change in modulation.Type: ApplicationFiled: July 22, 2020Publication date: November 5, 2020Inventors: PAUL STANLEY ADDISON, Daniel Wayne Bartlett, James N. Watson
-
Patent number: 10786198Abstract: Methods and systems are presented for determining physiological information in a physiological monitor. A physiological signal (e.g., an EEG signal) received from a subject is wavelet transformed and first and second related features that vary in scale over time are identified in the transformed signal. First and second coupled ridges of the respective first and second related features may also be identified in the transformed signal. A non-stationary relationship parameter is determined and is indicative of the relationship between the first and second features and/or between the first and second ridges. Physiological information, which may be indicative of a level of awareness of a subject, is determined based on the non-stationary relationship parameter.Type: GrantFiled: March 20, 2018Date of Patent: September 29, 2020Assignee: COVIDIEN LPInventors: Paul S. Addison, James N. Watson
-
Patent number: 10765344Abstract: Methods, systems, and devices for measuring respiratory parameters from an ECG device are described. The method may include receiving an electrocardiogram (ECG) signal associated with a patient. The method may further include detecting a change in modulation of the ECG signal between a first portion of the ECG signal and a second portion of the ECG signal. The method may further include determining a change in respiratory effort of the patient based at least in part on the change in modulation.Type: GrantFiled: November 2, 2017Date of Patent: September 8, 2020Assignee: Covidien LPInventors: Paul Stanley Addison, Daniel Wayne Bartlett, James N. Watson
-
Patent number: 10716503Abstract: Systems, methods, sensors, and software for providing enhanced measurement and detection of patient pain response are provided herein. In a first example, a measurement system is provided that includes a capacitive system configured to measure a capacitance signal of tissue of the patient using a capacitive sensor applied to the tissue of the patient. The measurement system also includes a patient monitor configured to measure an electrical signal representing brain activity of the patient using a brain activity sensor applied to the tissue of the patient. The measurement system also includes a processing system configured to determine pain metrics based at least on the capacitance signal and the electrical signal, and determine a pain response of the patient based at least on the pain metrics and pain calibration information for the patient.Type: GrantFiled: September 4, 2018Date of Patent: July 21, 2020Assignee: Covidien LPInventors: Paul S. Addison, James N. Watson, Eric Morland
-
SYSTEM AND METHOD FOR PROVIDING BLOOD PRESSURE SAFE ZONE INDICATION DURING AUTOREGULATION MONITORING
Publication number: 20200069195Abstract: A method for monitoring autoregulation includes, using a processor, using a processor to execute one or more routines on a memory. The one or more routines include receiving one or more physiological signals from a patient, determining a correlation-based measure indicative of the patient's autoregulation based on the one or more physiological signals, and generating an autoregulation profile of the patient based on autoregulation index values of the correlation-based measure. The autoregulation profile includes the autoregulation index values sorted into bins corresponding to different blood pressure ranges. The one or more routines also include designating a blood pressure range encompassing one or more of the bins as a blood pressure safe zone indicative of intact regulation and providing a signal to a display to display the autoregulation profile and a first indicator of the blood pressure safe zone.Type: ApplicationFiled: November 6, 2019Publication date: March 5, 2020Inventors: Paul Stanley Addison, James N. Watson, Dean Montgomery -
System and method for providing blood pressure safe zone indication during autoregulation monitoring
Patent number: 10499818Abstract: A method for monitoring autoregulation includes, using a processor, using a processor to execute one or more routines on a memory. The one or more routines include receiving one or more physiological signals from a patient, determining a correlation-based measure indicative of the patient's autoregulation based on the one or more physiological signals, and generating an autoregulation profile of the patient based on autoregulation index values of the correlation-based measure. The autoregulation profile includes the autoregulation index values sorted into bins corresponding to different blood pressure ranges. The one or more routines also include designating a blood pressure range encompassing one or more of the bins as a blood pressure safe zone indicative of intact regulation and providing a signal to a display to display the autoregulation profile and a first indicator of the blood pressure safe zone.Type: GrantFiled: October 18, 2016Date of Patent: December 10, 2019Assignee: Covidien LPInventors: Paul Stanley Addison, James N. Watson, Dean Montgomery -
Patent number: 10499835Abstract: Methods and systems are provided for determining fluid responsiveness in the presence of noise. The system may determine an instantaneous value indicative of fluid responsiveness. In some embodiments, the system may determine a difference between an instantaneous value indicative of fluid responsiveness and a previous value indicative of fluid responsiveness, and select an update characteristic based on whether the difference indicates that the fluid responsiveness is increasing or decreasing. In some embodiments, the system may determine a parameter indicative of fluid responsiveness based on the update characteristic and a previously reported value indicative of fluid responsiveness.Type: GrantFiled: March 8, 2016Date of Patent: December 10, 2019Assignee: Covidien LPInventors: Paul S. Addison, Scott McGonigle, James N. Watson
-
Patent number: 10463292Abstract: A system configured to monitor autoregulation includes a medical sensor configured to be applied to a patient and to generate a regional oxygen saturation signal. The system includes a controller having a processor configured to receive the regional oxygen saturation signal and a blood pressure signal and to determine a cerebral oximetry index (COx) based on the blood pressure signal and the regional oxygen saturation signal. The processor is also configured to apply a data clustering algorithm to cluster COx data points over a range of blood pressures, identify a first cluster of COx data points that corresponds to an intact autoregulation zone for the patient, and provide a first output indicative of the intact autoregulation zone for the patient.Type: GrantFiled: October 14, 2016Date of Patent: November 5, 2019Assignee: Covidien LPInventors: Paul Stanley Addison, James N. Watson, Dean Montgomery